Lesser Toe PIP Joint Arthrodesis Versus Resection Arthroplasty

Sponsor
University Hospital Tuebingen (Other)
Overall Status
Completed
CT.gov ID
NCT03530839
Collaborator
(none)
37
2
28

Study Details

Study Description

Brief Summary

Background: The aim of this study was to compare operative outcomes after lesser toe deformity correction with either proximal interphalangeal (PIP) joint arthrodesis or PIP joint resection arthroplasty.

Methods: A prospective randomized controlled trial was performed on 37 patients (48 toes) who underwent one of these two procedures. The Numeric Rating Scale (NRS) for pain, American Orthopaedic Foot and Ankle Society (AOFAS) score, osseous consolidation, and clinical outcome were evaluated preoperatively and at 6 weeks and 6 months postoperatively.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Arthrodesis
  • Procedure: Resection arthroplasty
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
37 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Treatment
Official Title:
Lesser Toe PIP Joint Arthrodesis Versus Resection Arthroplasty: A Randomized Controlled Study
Actual Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
May 1, 2017
Actual Study Completion Date :
May 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arthrodesis

Arthrodesis of the proximal interphalangeal joint by using a threaded K-wire

Procedure: Arthrodesis
see study group description

Active Comparator: Resection arthroplasty

Resection arthroplasty of the proximal interphalangeal joint using a normal K-wire

Procedure: Resection arthroplasty
see study group description

Outcome Measures

Primary Outcome Measures

  1. Pain [Change from preoperatively to 6 weeks postoperatively and to 6months postoperatively]

    Change in pain was evaluated using the Numeric Rating Scale for pain (ranging from 0 (no pain) to 10 (maximum pain))

  2. Function [Change from preoperatively to 6 weeks postoperatively and to 6months postoperatively]

    Change in function was evaluated using the American Orthopaedic Foot and Ankle Society score (ranging from 0 (severe impairment) to 100 (no problems with foot))

Secondary Outcome Measures

  1. Osseous consolidation [6months postoperatively]

    Osseous consolidation of the procedure was evaluated using x-rays

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with one or more claw toes with rigid PIP joint flexion and extension deformity of the MTP joint scheduled for surgical intervention in the investigator's department
Exclusion Criteria:
  • known osteoporosis or other bone metabolism disorders

  • prior surgery on the toe scheduled for the intervention

  • immunodeficiency or immunosuppressive drug intake

  • pregnancy

  • non-palpable pulses of the posterior tibial artery or the dorsalis pedis artery

  • anticoagulation therapy with the exception of acetylsalicylic acid

  • a lack of sufficient physical resilience to allow free self-mobilization and walking.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University Hospital Tuebingen

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Ulf Krister Hofmann, Senior physician, University Hospital Tuebingen
ClinicalTrials.gov Identifier:
NCT03530839
Other Study ID Numbers:
  • 450/2014BO1
First Posted:
May 21, 2018
Last Update Posted:
May 21, 2018
Last Verified:
May 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr. Ulf Krister Hofmann, Senior physician, University Hospital Tuebingen
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 21, 2018